Cargando…

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ

INTRODUCTION: Heparan sulphate proteoglycan syndecan-1 modulates cell proliferation, adhesion, migration and angiogenesis. It is a coreceptor for the hepatocyte growth factor receptor c-met, and its coexpression with E-cadherin is synchronously regulated during epithelial-mesenchymal transition. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Götte, Martin, Kersting, Christian, Radke, Isabel, Kiesel, Ludwig, Wülfing, Pia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851383/ https://www.ncbi.nlm.nih.gov/pubmed/17244359 http://dx.doi.org/10.1186/bcr1641

Ejemplares similares

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

Establishment of a 3D co‐culture model to investigate the role of primary fibroblasts in ductal carcinoma in situ of the breast
por: Sourouni, Marina, et al.
Publicado: (2022)

Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ
por: Wülfing, P, et al.
Publicado: (2005)

Syndecan-1 (CD138), Carcinomas and EMT
por: Couchman, John R.
Publicado: (2021)

Caveolin-1 expression in benign and malignant lesions of the breast
por: Liedtke, Cornelia, et al.
Publicado: (2007)

Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
por: Ibrahim, Sherif A., et al.
Publicado: (2013)

Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes
por: Nassar, Eyyad, et al.
Publicado: (2021)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis
por: Hillemeyer, Lara, et al.
Publicado: (2022)

Angiogenesis and Lymphangiogenesis of Gastric Cancer
por: Kitadai, Yasuhiko
Publicado: (2010)

Angiogenesis, lymphangiogenesis and clinical implications
por: Naik, Sita
Publicado: (2015)

Angiogenesis and Lymphangiogenesis in Medulloblastoma Development
por: Penco-Campillo, Manon, et al.
Publicado: (2023)

Syndecan-3 in Inflammation and Angiogenesis
por: Arokiasamy, Samantha, et al.
Publicado: (2020)

Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
por: Oto, Julia, et al.
Publicado: (2023)

The Intensity and Pattern of Syndecan-1 (CD138) Expression in Normal and Diseased Livers
por: Atique, Muhammad, et al.
Publicado: (2023)

Lymphangiogenesis and Angiogenesis in Abdominal Aortic Aneurysm
por: Sano, Masaki, et al.
Publicado: (2014)

The role of lymphangiogenesis and angiogenesis in tumor metastasis
por: Paduch, Roman
Publicado: (2016)

The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors
por: Wasik, Adrian, et al.
Publicado: (2022)

Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
por: Hilgers, Katharina, et al.
Publicado: (2022)

Shed syndecan-2 inhibits angiogenesis
por: De Rossi, Giulia, et al.
Publicado: (2014)

Syndecan-1 as a Regulator of Chemokine Function
por: Götte, Martin, et al.
Publicado: (2003)

Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
por: Boneberg, E-M, et al.
Publicado: (2009)

The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4(+) T cell polarization in inflammatory and non-inflammatory breast cancer patients
por: Saleh, Moshira Ezzat, et al.
Publicado: (2019)

A novel role for syndecan-3 in angiogenesis
por: De Rossi, Giulia, et al.
Publicado: (2013)

Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations
por: Sharma, Monica, et al.
Publicado: (2018)

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues
por: Kind, Simon, et al.
Publicado: (2019)

Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas
por: Carreón-Burciaga, Ramón G., et al.
Publicado: (2018)

Angiogenesis and Lymphangiogenesis in the Spectrum of Leprosy and Its Reactional Forms
por: Soares, Cleverson Teixeira, et al.
Publicado: (2013)

Lymphangiogenesis and angiogenesis during human fetal pancreas development
por: Roost, Matthias S, et al.
Publicado: (2014)

Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
por: Riabov, Vladimir, et al.
Publicado: (2014)

Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
por: Sammarco, Giuseppe, et al.
Publicado: (2019)

Increased Angiogenesis and Lymphangiogenesis in Adenomyosis Visualized by Multiplex Immunohistochemistry
por: Harmsen, Marissa J., et al.
Publicado: (2022)

Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma?
por: Lee, Je-Jung
Publicado: (2010)

Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus
por: Liu, Lunhua, et al.
Publicado: (2020)

Utility of CD138/syndecan-1 immunohistochemistry for localization of plasmacytes is tissue-dependent in B6 mice
por: Meyerholz, David K., et al.
Publicado: (2022)

Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies
por: Cigliana, Giovanni, et al.
Publicado: (2015)

M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
por: Kubota, Yoshiaki, et al.
Publicado: (2009)

PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis
por: Nassar, Zeyad D., et al.
Publicado: (2013)

Parallels of Resistance between Angiogenesis and Lymphangiogenesis Inhibition in Cancer Therapy
por: Jones, Dennis
Publicado: (2020)

Characterization of the sex-specific pattern of angiogenesis and lymphangiogenesis in aortic stenosis
por: Matilla, Lara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sureeapo5ghk82kp9cptr0iu2u